153 related articles for article (PubMed ID: 37330316)
1. Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 Autoantibodies.
Abel A; Lazaro E; Ralazamahaleo M; Pierrisnard E; Suzon B; Bonnet F; Mercié P; Macey J; Agossou M; Viallard JF; Deligny C; Rivière E
Eur J Intern Med; 2023 Sep; 115():104-113. PubMed ID: 37330316
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.
Pinal-Fernandez I; Casal-Dominguez M; Huapaya JA; Albayda J; Paik JJ; Johnson C; Silhan L; Christopher-Stine L; Mammen AL; Danoff SK
Rheumatology (Oxford); 2017 Jun; 56(6):999-1007. PubMed ID: 28339994
[TBL] [Abstract][Full Text] [Related]
3. Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome.
Martins P; Dourado E; Melo AT; Samões B; Sousa M; Freitas R; Lourenço MH; Fernandes B; Costa E; Parente H; Martins F; Fonseca JE; Cordeiro I; Romão VC; Khmelinskii N; Campanilho-Marques R
ARP Rheumatol; 2022 Nov; 1(ARP Rheumatology, nº3 2022):190-196. PubMed ID: 35891592
[TBL] [Abstract][Full Text] [Related]
4. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
[TBL] [Abstract][Full Text] [Related]
5. Outcome of anti-PL12 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Dominique S; Landron C; Roblot P; Jouneau S; Vittecoq O; Jouen F
Presse Med; 2013 Jun; 42(6 Pt 1):e153-8. PubMed ID: 23428662
[TBL] [Abstract][Full Text] [Related]
6. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Dominique S; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Tiev KP; Vittecoq O; Noel D; Mouthon L; Menard JF; Jouen F
Autoimmun Rev; 2012 Aug; 11(10):739-45. PubMed ID: 22326685
[TBL] [Abstract][Full Text] [Related]
7. [Antisynthetase syndrome: a retrospective study of 14 patients].
Dieval C; Ribeiro E; Mercié P; Blanco P; Duffau P; Longy-Boursier M
Rev Med Interne; 2012 Feb; 33(2):76-9. PubMed ID: 22204922
[TBL] [Abstract][Full Text] [Related]
8. Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
Shi J; Li S; Yang H; Zhang Y; Peng Q; Lu X; Wang G
J Rheumatol; 2017 Jul; 44(7):1051-1057. PubMed ID: 28461650
[TBL] [Abstract][Full Text] [Related]
9. Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional study.
Rivero-Gallegos D; Mejía M; Rocha-González HI; Huerta-Cruz JC; Falfán-Valencia R; Ramos-Martínez E; Mateos-Toledo HN; Castillo-López MF; Rodríguez-Torres YK; Lira-Boussart V; Rojas-Serrano J
Clin Rheumatol; 2024 Apr; ():. PubMed ID: 38642252
[TBL] [Abstract][Full Text] [Related]
10. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.
Hervier B; Devilliers H; Stanciu R; Meyer A; Uzunhan Y; Masseau A; Dubucquoi S; Hatron PY; Musset L; Wallaert B; Nunes H; Maisonobe T; Olsson NO; Adoue D; Arlet P; Sibilia J; Guiguet M; Lauque D; Amoura Z; Hachulla E; Hamidou M; Benveniste O
Autoimmun Rev; 2012 Dec; 12(2):210-7. PubMed ID: 22771754
[TBL] [Abstract][Full Text] [Related]
11. Mechanic's hands in a woman with undifferentiated connective tissue disease and interstitial lung disease--anti-PL7 positive antisynthetase syndrome: a case report.
De Langhe E; Lenaerts J; Bossuyt X; Westhovens R; Wuyts WA
J Med Case Rep; 2015 Apr; 9():82. PubMed ID: 25888844
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Hachulla E; Vittecoq O; Menard JF; Jouen F; Dominique S
Eur J Intern Med; 2013 Jul; 24(5):474-9. PubMed ID: 23375620
[TBL] [Abstract][Full Text] [Related]
13. Interstitial Lung Disease and Myositis in a Patient With Antisynthetase Syndrome and PL12 and Ro52 Co-positivity in a Retired Medical Officer.
Loncharich MF; Anderson CW; Collins J; Edison J
Mil Med; 2021 Jul; 186(7-8):e836-e839. PubMed ID: 33200774
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: Results from the MYONET registry.
Hum RM; Lilleker JB; Lamb JA; Oldroyd AGS; Wang G; Wedderburn LR; Diederichsen LP; Schmidt J; Danieli MG; Oakley P; Griger Z; Phuong TNT; Kodishala C; Vazquez-Del Mercado M; Andersson H; De Paepe B; De Bleecker JL; Maurer B; McCann L; Pipitone N; McHugh N; New RP; Ollier WE; Krogh NS; Vencovsky J; Lundberg IE; ; Chinoy H
Rheumatology (Oxford); 2023 Sep; ():. PubMed ID: 37698987
[TBL] [Abstract][Full Text] [Related]
15. Mechanics hands in patients with antisynthetase syndrome: 25 cases.
Gusdorf L; Morruzzi C; Goetz J; Lipsker D; Sibilia J; Cribier B
Ann Dermatol Venereol; 2019 Jan; 146(1):19-25. PubMed ID: 30595338
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and radiological features of adult patients with different antisynthetase syndrome based on serum anti-aminoacyl-tRNA synthetase antibody type].
Li S; Huang H; Song XY; Xu K; Wu CY; Wang Q; Xu ZJ
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Dec; 40(12):919-924. PubMed ID: 29224302
[No Abstract] [Full Text] [Related]
17. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations and treatment of antisynthetase syndrome.
Marco JL; Collins BF
Best Pract Res Clin Rheumatol; 2020 Aug; 34(4):101503. PubMed ID: 32284267
[TBL] [Abstract][Full Text] [Related]
19. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
Stanciu R; Guiguet M; Musset L; Touitou D; Beigelman C; Rigolet A; Costedoat-Chalumeau N; Allenbach Y; Hervier B; Dubourg O; Maisonobe T; Charuel JL; Behin A; Herson S; Amoura Z; Grenier P; Benveniste O
J Rheumatol; 2012 Sep; 39(9):1835-9. PubMed ID: 22859355
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome.
Liu H; Xie S; Liang T; Ma L; Sun H; Dai H; Wang C
Eur Radiol; 2019 Oct; 29(10):5349-5357. PubMed ID: 30919069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
